Sarah Ash

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


3 publications

2024 | 2023 |
2024
Targeting the activated microenvironment with endosialin (CD248)-directed CAR-T cells ablates perivascular cells to impair tumor growth and metastasis.
Ash S.L., Orha R., Mole H., Dinesh-Kumar M., Lee S.P., Turrell F.K., Isacke C.M., 2024/02/27. Journal for immunotherapy of cancer, 12 (2). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FB9968E11166]
2023
Coengineering specificity, safety, and function into T cells for cancer immunotherapy.
Giordano Attianese GMP, Ash S., Irving M., 2023/11. Immunological reviews, 320 (1) pp. 166-198. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_777D795B1683]
A lentiviral vector for the production of T cells with an inducible transgene and a constitutively expressed tumour-targeting receptor.
Reichenbach P., Giordano Attianese GMP, Ouchen K., Cribioli E., Triboulet M., Ash S., Saillard M., Vuillefroy de Silly R., Coukos G., Irving M., 2023/09. Nature biomedical engineering, 7 (9) pp. 1063-1080. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_22CADB5FE4EC]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University